(Total Views: 203)
Posted On: 10/14/2022 8:39:32 AM
Post# of 25770
Live on SSN Network on the effectiveness of TCM in treating COVID19 #RGC
Regencell Bioscience Limited is a Hong Kong-based firm that is pioneering the use of Traditional Chinese Medicine ("TCM"
to cure not just ADHD and ASD, but also the Covid-19 virus, which shocked the globe in 2020.
RGC now offers a therapy formula that has been tested on 19 individuals (suspected or confirmed COVID cases). After an average of 5 days of therapy, 12 of 19 patients showed signs of progress in their recovery.
[https://finance.yahoo.com/news/regencell-describes-traditional-chinese-medicine-133000084.html](https://finance.yahoo.com/news/regencell-describes-traditional-chinese-medicine-133000084.html)
Separately, while Mr Au, the business's CEO and chairman, was not present for the interview, he has been working behind the scenes to protect his company from recent short seller and trader attacks on the company's shares. Since the company's IPO, Mr Au has purchased nearly $5 million in stock.
"While research is still underway," Mr Au stated, "We are certain that our formula can make a difference in the fight against COVID-19."
Regencell Bioscience Limited is a Hong Kong-based firm that is pioneering the use of Traditional Chinese Medicine ("TCM"
to cure not just ADHD and ASD, but also the Covid-19 virus, which shocked the globe in 2020. RGC now offers a therapy formula that has been tested on 19 individuals (suspected or confirmed COVID cases). After an average of 5 days of therapy, 12 of 19 patients showed signs of progress in their recovery.
[https://finance.yahoo.com/news/regencell-describes-traditional-chinese-medicine-133000084.html](https://finance.yahoo.com/news/regencell-describes-traditional-chinese-medicine-133000084.html)
Separately, while Mr Au, the business's CEO and chairman, was not present for the interview, he has been working behind the scenes to protect his company from recent short seller and trader attacks on the company's shares. Since the company's IPO, Mr Au has purchased nearly $5 million in stock.
"While research is still underway," Mr Au stated, "We are certain that our formula can make a difference in the fight against COVID-19."
(0)
(0)
